SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+29.39%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$1.42B
AUM Growth
+$1.42B
(+22%)
Cap. Flow
+$99.8M
Cap. Flow
% of AUM
7.03%
Top 10 Holdings %
Top 10 Hldgs %
29.29%
Holding
112
New
24
Increased
30
Reduced
36
Closed
15
Top Buys
| 1 |
Atea Pharmaceuticals
AVIR
|
$62.3M |
| 2 |
Maravai LifeSciences
MRVI
|
$27.5M |
| 3 |
Replimune Group
REPL
|
$25.5M |
| 4 |
Tandem Diabetes Care
TNDM
|
$23.8M |
| 5 |
Certara
CERT
|
$20.4M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$51M |
| 2 |
HMSY
HMS Holdings Corp.
HMSY
|
$18.7M |
| 3 |
Zentalis Pharmaceuticals
ZNTL
|
$18.2M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$17.7M |
| 5 |
Assembly Biosciences
ASMB
|
$15.1M |
Sector Composition
| 1 | Healthcare | 96.8% |
| 2 | Industrials | 1.99% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Atea Pharmaceuticals
AVIR
$267M
| $62.3M | 4.39% | +1,492,090 | New | +$62.3M |
|
2
Arvinas
ARVN
$568M
| $45.2M | 3.18% | 532,125 -169,387 | -24% | -$14.4M |
|
|
3
Tandem Diabetes Care
TNDM
$845M
| $45.1M | 3.18% | 471,818 +248,850 | +112% | +$23.8M |
|
4
Teladoc Health
TDOC
$1.37B
| $42M | 2.96% | 209,859 +93,520 | +80% | +$18.7M |
|
5
Labcorp
LH
$23.1B
| $41.2M | 2.9% | 202,237 +27,625 | +16% | +$5.62M |
|
6
PTC Therapeutics
PTCT
$3.92B
| $36.9M | 2.6% | 603,978 -65,600 | -10% | -$4M |
|
7
Exelixis
EXEL
$10.1B
| $36.2M | 2.55% | 1,802,270 +945,500 | +110% | +$19M |
|
8
AtriCure
ATRC
$1.84B
| $35.9M | 2.53% | 644,217 -64,500 | -9% | -$3.59M |
|
9
Teleflex
TFX
$5.59B
| $35.5M | 2.5% | 86,193 +13,675 | +19% | +$5.63M |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $35.4M | 2.5% | 1,534,604 -619,029 | -29% | -$14.3M |
|
11
Acadia Pharmaceuticals
ACAD
$4.38B
| $35M | 2.47% | 654,414 +97,900 | +18% | +$5.23M |
|
|
PPD
12
DELISTED
PPD, Inc. Common Stock
PPD
| $33.4M | 2.36% | 977,154 +14,100 | +1% | +$482K |
|
13
Evolent Health
EVH
$1.12B
| $32.8M | 2.31% | 2,048,257 -38,178 | -2% | -$612K |
|
|
TPTX
14
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $31.4M | 2.21% | 257,379 +6,898 | +3% | +$841K |
|
|
AFIB
15
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $28.3M | 1.99% | 982,236 +450,078 | +85% | +$13M |
|
|
RCM
16
DELISTED
R1 RCM Inc. Common Stock
RCM
| $28.2M | 1.99% | 1,174,393 -366,000 | -24% | -$8.79M |
|
|
DCPH
17
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $27.9M | 1.97% | 488,842 +72,783 | +17% | +$4.15M |
|
|
18
Maravai LifeSciences
MRVI
$350M
| $27.5M | 1.93% | +978,600 | New | +$27.5M |
|
|
19
Replimune Group
REPL
$422M
| $25.5M | 1.8% | +667,729 | New | +$25.5M |
|
20
iRhythm Technologies
IRTC
$5.46B
| $25.3M | 1.78% | 106,565 +3,000 | +3% | +$712K |
|
|
SILK
21
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $25.2M | 1.77% | 399,483 +11,500 | +3% | +$724K |
|
22
Novavax
NVAX
$1.21B
| $24.9M | 1.76% | 223,350 +105,150 | +89% | +$11.7M |
|
23
Align Technology
ALGN
$10.3B
| $24.7M | 1.74% | 46,150 +9,850 | +27% | +$5.26M |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $24.6M | 1.73% | 320,059 -89,846 | -22% | -$6.9M |
|
25
Repligen
RGEN
$6.88B
| $23.8M | 1.68% | 124,193 +22,200 | +22% | +$4.25M |
|